LIFECORE BIOMEDICAL, INC. DE (LFCR): Nasdaq/NYSE listing notice — Lifecore receives Nasdaq delisting notice for delayed filings; compliance plan submitted

LIFECORE BIOMEDICAL, INC. DE

Received Nasdaq notice on Oct 12, 2023 for failure to timely file Form 10-Q (period ended Aug 27, 2023) and still-delinquent Form 10-K (period ended May 28, 2023).
Submitted compliance plan on Oct 16, 2023; if accepted, Nasdaq may grant up to 180 days from Form 10-K due date (Feb 12, 2024) to regain compliance.
No immediate impact on listing or trading of common stock on Nasdaq Global Select Market.
Company states it is working diligently to complete and file the delinquent reports as promptly as possible.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

LIFECORE BIOMEDICAL, INC. DE received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

n filing its Annual Report on Form 10-K for the period ended May 28, 2023 (the “Form 10-K” and, together with the Form 10-Q, the “Filings”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The notification letter has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Global Select Market. In accordance with the instructions contained in the Notice, the Company submitted a plan to regain compliance with the Listing

View on SEC.gov

8 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

LIFECORE BIOMEDICAL, INC. DE filing history →

Source: SEC EDGAR

accession 0001005286-23-000116

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.